Navigation

Osteoporotic fractures - denosumab

Denosumab for the prevention of osteoporotic fractures in postmenopausal women

Status: History
Expected date of issue: October 2010
Referral date: November 2008
Process: STA
Topic area:
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Fay McCracken
Communications manager: Tonya Gillis
Project manager: Kate Moore
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 21 January 2010
1st appraisal committee meeting: 27 April 2010
2nd appraisal committee meeting 27 July 2010
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Amgen (denosumab)

Patient/carer groups

  • National Osteoporosis Society

Professional groups

  • British Health Professionals in Rheumatology
  • British Society for Rheumatology
  • Primary Care Rheumatology Society
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians
  • Royal College of Radiologists
  • Society for Endocrinology

Others

  • Department of Health
  • Coventry Teaching PCT
  • Welsh Assembly Government

General

  • Commissioning Support Appraisals Service
  • NHS Quality Improvement Scotland

Comparator manufacturer(s)

  • Novartis (calcitonin, zoledronic acid)
  • Pfizer (lasofoxifene)
  • Roche (calcitriol, ibandronic acid)
  • Warner Chilcott

Relevant research groups

  • None

Evidence Review Group

  • Aberdeen HTA Group
  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Top


 

Project history

Date Update
17 May 2010 The issue of an Appraisal Consultation Document was delayed pending further information from the manufacturer.  This is in accordance with the Single Technology Appraisal process that an ACD can only be released after UK regulatory approval has been granted, and after the technology’s price and indication are known. 
Top


 

Key documents

This page was last updated: 27 October 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.